Document is current
Any future updates will be listed below
-
Authors
Fedewa, Stacey A.
Buckner, Tyler W.
Parks, Sara Guasch
Tran, Duc Q.
Cafuir, Lorraine
Antun, Ana G.
Mattis, Shanna
Kempton, Christine L.
- License Information
-
More Information
Article History
Received: 20 January 2023
Revised: 24 April 2023
Accepted: 25 April 2023
First Online: 3 May 2023
Declarations
:
: This study was approved by the Emory University Institutional Review Board.
: All participants consented to participate.
: All participants consented to participate/were informed of publication.
: CLK has received honoraria from Spark Therapeutics, Octapharma, Genetech, and Pfizer and research support from Novo Nordisk. TWB has acted as a paid consultant to BioMarin, Tremeau Pharmaceuticals, and UniQure and has participated in advisory boards with Takeda, Tremeau, Novo Nordisk, Genentech/ Roche, Spark, Pfizer, Bayer and Kedrion. All other authors have no disclosures.
